USFDA completes audit at Dr. Reddy’s API Hyderabad plant

16 Mar 2018 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Hyderabad plant I at Jinnaram Mandal, Medak District, Telangana on March 16, 2018. USFDA has issued a Form 483 with four observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×